He is completely against the clock watcher mentality so prevalent in health care
NOTICE: Not for human or animal consumption.
According to the World Health Organization, obesity prevalence has nearly tripled since 1975, and it is associated with increased risks of developing chronic diseases such as type 2 diabetes, cardiovascular disease, and certain types of cancer
Additional Use Cases in the Pipeline GLP-1s were a big deal for diabetes, then became a bigger deal for weight loss
The challenge was that natural incretins break down within minutes of release
GLP-1 analogues as GLP-1 receptor activators Most GLP-1 receptor agonists in clinical use are GLP-1 analogues, that is, peptide formulations based on native GLP-1 and showing a high degree of similarity to native GLP-1